Leung, Cindy W.
Tapper, Elliot B.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (UO1DK130113)
Article History
Received: 31 May 2024
Accepted: 14 February 2025
First Online: 21 February 2025
Declarations
:
: Elliot Tapper has served as a consultant to Norvartis, Axcella, and Allergan, has served on advisory boards for Mallinckrodt, Bausch Health, Kaleido, Novo Nordisk, and has received unrestricted research grants from Gilead and Valeant. No other author has a conflict of interest.